BAYZED HEALTH (02609) saw its shares drop more than 6% during the morning trading session, hitting a new intraday low of HK$2.65 and setting a fresh record low since its listing. As of the time of writing, the stock was down 4.59%, trading at HK$2.70, with a turnover of HK$5.84 million. Market sources indicate that the Hong Kong stock market is experiencing a new wave of restricted share unlock events in March. Among them, BAYZED HEALTH is scheduled to have its lockup period expire on March 24, with approximately 25.2% of its shares becoming eligible for trading. It is worth noting that BAYZED HEALTH has undergone frequent personnel changes recently. In September 2025, Zhao Yongkai resigned as Chairman of the Board and was succeeded by Dr. Chen Haoyang as Chairman; Liu Yan and Dr. Du Hongwei were appointed as Vice Presidents, while Yao Le was appointed as Board Secretary. At the end of December, Lü Chao was appointed as the company's President; on the same day, Dr. Jiang Zheng, the Assistant President, resigned due to personal reasons.